StonvexLoading…
StonvexStonvexStonvexCore line items from ALNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $554.48M | $529.97M | $578.63M | $502.99M |
Operating Income | $43.98M | $30.04M | $42.31M | $31.66M |
Net Income | $22.03M | $13.17M | $24.10M | $17.39M |
EPS (Diluted) | $1.32 | $0.79 | $1.48 | $1.09 |
Total Assets | $577.60M | $575.78M | $597.54M | $588.35M |
Total Liabilities | $276.14M | $310.93M | $345.97M | $372.88M |
Cash & Equivalents | $40.70M | $36.10M | $31.90M | $30.61M |
Free Cash Flow OCF − CapEx | $49.69M | $32.17M | $33.44M | $-10.31M |
Shares Outstanding | 16.94M | 16.81M | 16.31M | 15.98M |